Markets.com Logo

ICHR

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    16.7408$
  • Previous Close
    16.8725$
  • 52 Week Change
    23.36$
  • Day Range
    -0.13$
  • 52 Week High/Low
    13.12$ - 36.48$
  • Dividend Per Share
    --
  • Market cap
    581 M$
  • EPS
    0.03
  • Beta
    1.752
  • Volume
    --

About

ICHR.US represents the common stock of Ichor Holdings, Ltd. traded on the Nasdaq Stock Market in the United States. Ichor Holdings is a company that designs, engineers, and manufactures critical fluid delivery subsystems and process equipment for semiconductor manufacturing. Their products are used in various semiconductor fabrication processes, including etching, deposition, and cleaning. The company provides these systems and related services to leading semiconductor equipment manufacturers globally. Investors can track the performance of ICHR.US to monitor the company's financial health and its impact on the semiconductor industry.

Gold Volatility: Is a Structural Shift Underway? An In-depth Analysis

Noah Lee|--

S&P 500's Record Rally Continues: Nomura Strategist Flags Two Key Exit Signals

Liam James|--

Trump's Papal Challenge: A Clash Over Moral Authority and Political Influence

Noah Lee|--

Global Markets Show Resilience Amidst Iran Conflict, But Underlying Risks Persist

Emma Rose|--

Iran War Threatens US Labor Market's 'Wonderful Balance': A Deep Dive

Emma Rose|--

Iran's Hormuz Toll Strategy: Post-War Economic Leverage and Geopolitical Realignment

Sophia Claire|--

US Labor Market Outlook: Balancing Recovery Against Escalating Geopolitical Risks

Sophia Claire|--

Factors

ICHR.US Price Drivers Company Performance: Revenue growth, profitability, and successful drug development outcomes directly influence investor confidence and stock price. Regulatory Decisions: FDA approvals or rejections of ICHR's drug candidates significantly impact the stock's valuation. Market Sentiment: Overall investor risk appetite and sector-specific trends (e.g., biotech optimism) can affect ICHR's price. Clinical Trial Results: Positive or negative data from clinical trials are major catalysts for price fluctuations. Competition: The emergence of competing drugs or therapies can erode ICHR's market share and stock value. Economic Conditions: Broader economic factors like interest rates and inflation can affect investment in biotech stocks. Partnerships & Acquisitions: Strategic collaborations or potential acquisitions can boost investor confidence and stock price. Management Changes: Significant changes in leadership can create uncertainty or optimism, influencing the stock's direction.

People Also Watch

Latest news

Japan's Central Bank Poised for Rate Hike Amidst Heightened Middle East Tensions

Ava Grace|--

US Stocks Hit Record Highs as Geopolitical Fears Ease, Tech Bet Surge

Ava Grace|--

Fed Chair Succession Sparks Legal Battle Over Independence

Noah Lee|--

Latest Education Articles

Bonds vs. Stocks in CFD Trading: What Traders Need to Understand

Bonds vs. Stocks in CFD Trading: What Traders Need to Understand

Julian Parker|--
Crypto Trends in 2026: 7 Key Developments Every Investor Should Watch

Crypto Trends in 2026: 7 Key Developments Every Investor Should Watch

Julian Parker|--
Beginners Guide to Fundamental Analysis: What Are the 5 Key Principles of Fundamental Analysis?

Beginners Guide to Fundamental Analysis: What Are the 5 Key Principles of Fundamental Analysis?

Frances Wang|--
Recommended Topics